AHA 2015
Apixaban Efficacy, Safety Evaluated in AF Patient on Multiple Concomitant Medications
Older patients, females, and those with comorbidities were more likely to be on multiple medications.
Your search for apixaban returned 4 results
AHA 2017 Scientific Sessions
Does Use of Apixaban With Cardiac P-gp Inhibitors Up Bleeding Risk?
Apixaban is a substrate of P-glycoprotein and P-glycoprotein inhibition increases drug exposure.
ACC.18
Interim Data Show Andexanet Alfa Rapidly Reverses Anti-Factor Xa Activity
ANNEXA-4 is a global, single-arm, open-label clinical trial designed to evaluate andexanet alfa in patients who present with an acute major bleed while receiving apixaban, rivaroxaban, edoxaban or enoxaparin.
AHA 2017 Scientific Sessions
Direct Oral Anticoagulant Use Increasing in Dialysis Patients With AFib
End-stage renal disease patients on dialysis with atrial fibrillation are at high risk for thrombotic complications.
